[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling

Oncol Rep. 2023 May;49(5):81. doi: 10.3892/or.2023.8518. Epub 2023 Mar 10.

Abstract

Subsequently to the publication of this paper, the authors have realized that an error was made during the compilation of Fig. 2A as it appeared on p. 4. Essentially, the partial Q2‑3 images of the '1.56 µm' group were inadvertently copied across to the Q2‑3 images of the '3.12 µm' group, leading to the cell number of the Q2‑3 quadrant being the same for both the 1.56 µm and the 3.12 µm groups, and also leading the total cell number of the 3.12 µm group being calculated as 106.97%, which was clearly incorrect (the total percentage should have added up to 100%). The corrected version of Fig. 2, showing the correct data for the Q2‑3 images in the '3.12 µm' group, is shown on the next page. Note that this error did not significantly affect the results or the conclusions reported in this paper, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of Oncology Reports for allowing them this opportunity to publish a corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 46: 136, 2021; DOI: 10.3892/or.2021.8087].

Keywords: BCR‑ABL; ND‑09; cell apoptosis; cell cycle; chronic myeloid leukemia.

Publication types

  • Published Erratum